Accounted for 53% of the 63million prescriptions for ADHD drugs last year, according to data compiled by Shire Plc, which makes the top-selling Vyvanse treatment. That compared with 39% in 2007.
Accounted for 53% of the 63million prescriptions for ADHD drugs last year, according to data compiled by Shire Plc, which makes the top-selling Vyvanse treatment. That compared with 39% in 2007.